Stephen Tulipano
Corporate Officer/Principal chez The American Institute of Certified Public Accountants
Fortune : 242 521 $ au 30/04/2024
Profil
Stephen J.
Tulipano is currently a Member at The American Institute of Certified Public Accountants and a Member at the Massachusetts Society of Certified Public Accountants, Inc. Previously, he worked as the Director-Corporate Accounting at Biogen, Inc. from 1998 to 2006.
He also served as the Manager-External Reporting at Digital Equipment Corp.
Additionally, he held the position of Chief Financial Officer & Treasurer at Aldeyra Therapeutics, Inc. from 2014 to 2018 and Chief Financial Officer & Secretary at Javelin Pharmaceuticals, Inc. from 2009 to 2010.
Currently, he is the Chief Financial Officer at Stoke Therapeutics, Inc. from 2019 to 2024.
Mr. Tulipano obtained his undergraduate degree from Salem State University and his MBA from Sawyer Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
STOKE THERAPEUTICS, INC.
0,04% | 31/03/2024 | 20 746 ( 0,04% ) | 242 521 $ | 30/04/2024 |
Postes actifs de Stephen Tulipano
| Sociétés | Poste | Début |
|---|---|---|
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Corporate Officer/Principal | - |
Massachusetts Society of Certified Public Accountants, Inc.
 Massachusetts Society of Certified Public Accountants, Inc. Miscellaneous Commercial ServicesCommercial Services Massachusetts Society of Certified Public Accountants, Inc. provide services in public accounting, industry and business, government and education. The firm offers advocacy, continuing professional education, peer review, membership, communications and academic and career development department. The company was founded in 1900 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Anciens postes connus de Stephen Tulipano
| Sociétés | Poste | Fin |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Directeur Financier/CFO | 07/05/2024 |
| ALDEYRA THERAPEUTICS, INC. | Directeur Financier/CFO | 31/07/2018 |
Javelin Pharmaceuticals, Inc.
 Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA. | Directeur Financier/CFO | 01/07/2010 |
| BIOGEN INC. | Comptroller/Controller/Auditor | 01/04/2006 |
| Digital Equipment Corp. | Corporate Officer/Principal | - |
Formation de Stephen Tulipano
| Salem State University | Undergraduate Degree |
| Sawyer Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| ALDEYRA THERAPEUTICS, INC. | Health Technology |
| STOKE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Javelin Pharmaceuticals, Inc.
Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA. | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Commercial Services |
Massachusetts Society of Certified Public Accountants, Inc.
Massachusetts Society of Certified Public Accountants, Inc. Miscellaneous Commercial ServicesCommercial Services Massachusetts Society of Certified Public Accountants, Inc. provide services in public accounting, industry and business, government and education. The firm offers advocacy, continuing professional education, peer review, membership, communications and academic and career development department. The company was founded in 1900 and is headquartered in Boston, MA. | Commercial Services |
| Digital Equipment Corp. | Electronic Technology |